Bioventus Class A Inc (BVS)

R&D Expense Growth

28.62%

Quarterly · Period ending:

BVS logo

BVS R&D Expense Growth

Latest reported28.62%
BVS Quarterly R&D Growth (QoQ) (0.00% → 28.62%)
High-resolution chart · PNG

BVS r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bioventus Class A Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
28.6178%
-17.9581%
2.8738%
-7.8499%
5.3471%
-7.2397%
-14.7584%
-9.5487%
60.2589%
-19.4666%
8.1924%
-11.2713%
-9.8913%
-44.6011%
47.5293%
-27.5212%
-8.112%
-2.4637%
15.4396%
27.2333%
410.6653%
-67.2432%
-18.9969%
37.4807%
20.9692%
-31.743%
10.5097%
12.4062%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.